{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T18:40:48Z","timestamp":1788633648496,"version":"build-2803163510"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T00:00:00Z","timestamp":1774915200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T00:00:00Z","timestamp":1774915200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Department of Biotechnology (DBT), Ministry of Science and Technology, Government of India, New Delhi","award":["DBTHRDPMU\/JRF\/BET-23\/I\/2023-24\/85"],"award-info":[{"award-number":["DBTHRDPMU\/JRF\/BET-23\/I\/2023-24\/85"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s11033-026-11734-w","type":"journal-article","created":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T07:26:37Z","timestamp":1774941997000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Synergistic anticancer effects of thymoquinone and curcumin via ROS-mediated mitochondrial apoptosis in HeLa cells"],"prefix":"10.1007","volume":"53","author":[{"given":"Ummai","family":"Habiba","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Najmul","family":"Islam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,31]]},"reference":[{"issue":"3","key":"11734_CR1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, Jemal A (2024) Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Cancer J Clin 74(3):229\u2013263. https:\/\/doi.org\/10.3322\/caac.21834","journal-title":"Cancer J Clin"},{"issue":"10167","key":"11734_CR2","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/S0140-6736(18)32470-X","volume":"393","author":"PA Cohen","year":"2019","unstructured":"Cohen PA, Jhingran A, Oaknin A, Denny L (2019) Cervical cancer. Lancet (London England) 393(10167):169\u2013182. https:\/\/doi.org\/10.1016\/S0140-6736(18)32470-X","journal-title":"Lancet (London England)"},{"issue":"10","key":"11734_CR3","doi-asserted-by":"publisher","first-page":"4961","DOI":"10.3390\/ijms26104961","volume":"26","author":"E Tomaziu-Todosia Anton","year":"2025","unstructured":"Tomaziu-Todosia Anton E, Anton GI, Scripcariu IS, Dumitra\u0219cu I, Scripcariu DV, Balmus IM, Ionescu C, Visternicu M, Socolov DG (2025) Oxidative Stress, Inflammation, and Antioxidant Strategies in Cervical Cancer-A Narrative Review. Int J Mol Sci 26(10):4961. https:\/\/doi.org\/10.3390\/ijms26104961","journal-title":"Int J Mol Sci"},{"issue":"1","key":"11734_CR4","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s40779-022-00378-z","volume":"9","author":"X Lin","year":"2022","unstructured":"Lin X, Wang F, Chen J, Liu J, Lin YB, Li L, Chen CB, Xu Q (2022) N6-methyladenosine modification of CENPK mRNA by ZC3H13 promotes cervical cancer stemness and chemoresistance. Military Med Res 9(1):19. https:\/\/doi.org\/10.1186\/s40779-022-00378-z","journal-title":"Military Med Res"},{"issue":"9","key":"11734_CR5","doi-asserted-by":"publisher","first-page":"e3039","DOI":"10.1038\/cddis.2017.393","volume":"8","author":"HZ Cao","year":"2017","unstructured":"Cao HZ, Liu XF, Yang WT, Chen Q, Zheng PS (2017) LGR5 promotes cancer stem cell traits and chemoresistance in cervical cancer. Cell Death Dis 8(9):e3039\u2013e3039","journal-title":"Cell Death Dis"},{"issue":"12","key":"11734_CR6","doi-asserted-by":"publisher","first-page":"4363","DOI":"10.1007\/s11010-021-04249-4","volume":"476","author":"T Mitra","year":"2021","unstructured":"Mitra T, Elangovan S (2021) Cervical cancer development, chemoresistance, and therapy: a snapshot of involvement of microRNA. Mol Cell Biochem 476(12):4363\u20134385","journal-title":"Mol Cell Biochem"},{"issue":"27","key":"11734_CR7","doi-asserted-by":"publisher","first-page":"4201","DOI":"10.2174\/1381612822666160601100823","volume":"22","author":"M Hosein Farzaei","year":"2016","unstructured":"Hosein Farzaei M, Bahramsoltani R, Rahimi R (2016) Phytochemicals as adjunctive with conventional anticancer therapies. Curr Pharm Design 22(27):4201\u20134218","journal-title":"Curr Pharm Design"},{"key":"11734_CR8","doi-asserted-by":"publisher","first-page":"1614","DOI":"10.3389\/fphar.2019.01614","volume":"10","author":"AS Choudhari","year":"2020","unstructured":"Choudhari AS, Mandave PC, Deshpande M, Ranjekar P, Prakash O (2020) Phytochemicals in cancer treatment: From preclinical studies to clinical practice. Front Pharmacol 10:1614","journal-title":"Front Pharmacol"},{"issue":"1","key":"11734_CR9","first-page":"1189034","volume":"2022","author":"M Ayaz","year":"2022","unstructured":"Ayaz M, Nawaz A, Ahmad S, Mosa OF, Hamdoon E, Khalifa AA, Ananda Murthy MA, H. C (2022) Underlying anticancer mechanisms and synergistic combinations of phytochemicals with cancer chemotherapeutics: potential benefits and risks. J Food Qual 2022(1):1189034","journal-title":"J Food Qual"},{"issue":"1","key":"11734_CR10","first-page":"282570","volume":"2012","author":"K Sak","year":"2012","unstructured":"Sak K (2012) Chemotherapy and dietary phytochemical agents. Chemother Res Pract 2012(1):282570","journal-title":"Chemother Res Pract"},{"issue":"1","key":"11734_CR11","first-page":"6","volume":"5","author":"CG Awuchi","year":"2020","unstructured":"Awuchi CG (2020) The biochemistry, toxicology, and Uses of the acologically active phytochemicals: Alkaloids, terpenes, polyphenols, and glycosides. Merit Res Journals 5(1):6\u201321","journal-title":"Merit Res Journals"},{"key":"11734_CR12","doi-asserted-by":"publisher","unstructured":"Saboon Chaudhari SK, Arshad S, Amjad MS, Akhtar MS (2019) Natural Compounds Extracted from Medicinal Plants and Their Applications. In: Akhtar M, Swamy M, Sinniah, U (eds) Natural Bio-active Compounds. Springer, Singapore. https:\/\/doi.org\/10.1007\/978-981-13-7154-7_7","DOI":"10.1007\/978-981-13-7154-7_7"},{"key":"11734_CR13","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.lfs.2018.04.035","volume":"205","author":"P Mirzapur","year":"2018","unstructured":"Mirzapur P, Khazaei MR, Moradi MT, Khazaei M (2018) Apoptosis induction in human breast cancer cell lines by synergic effect of raloxifene and resveratrol through increasing proapoptotic genes. Life Sci 205:45\u201353","journal-title":"Life Sci"},{"issue":"18","key":"11734_CR14","doi-asserted-by":"publisher","first-page":"3911","DOI":"10.1080\/10408398.2016.1277971","volume":"57","author":"AF Majdalawieh","year":"2017","unstructured":"Majdalawieh AF, Fayyad MW, Nasrallah GK (2017) Anti-cancer properties and mechanisms of action of thymoquinone, the major active ingredient of Nigella sativa. Crit Rev Food Sci Nutr 57(18):3911\u20133928","journal-title":"Crit Rev Food Sci Nutr"},{"issue":"31","key":"11734_CR15","doi-asserted-by":"publisher","first-page":"51907","DOI":"10.18632\/oncotarget.17206","volume":"8","author":"MA Khan","year":"2017","unstructured":"Khan MA, Tania M, Fu S, Fu J (2017) Thymoquinone, as an anticancer molecule: from basic research to clinical investigation. Oncotarget 8(31):51907","journal-title":"Oncotarget"},{"key":"11734_CR16","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.phrs.2015.03.011","volume":"95","author":"S Darakhshan","year":"2015","unstructured":"Darakhshan S, Pour AB, Colagar AH, Sisakhtnezhad S (2015) Thymoquinone and its therapeutic potentials. Pharmacol Res 95:138\u2013158","journal-title":"Pharmacol Res"},{"key":"11734_CR17","doi-asserted-by":"publisher","first-page":"114972","DOI":"10.1016\/j.biopha.2023.114972","volume":"165","author":"H Shabani","year":"2023","unstructured":"Shabani H, Karami MH, Kolour J, Sayyahi Z, Parvin MA, Soghala S, Samarghandian S (2023) Anticancer activity of thymoquinone against breast cancer cells: Mechanisms of action and delivery approaches. Biomed Pharmacother 165:114972","journal-title":"Biomed Pharmacother"},{"issue":"17","key":"11734_CR18","doi-asserted-by":"publisher","first-page":"2420","DOI":"10.2174\/1389557521666210122153823","volume":"21","author":"P Joshi","year":"2021","unstructured":"Joshi P, Joshi S, Semwal D, Bisht A, Paliwal S, Dwivedi J, Sharma S (2021) Curcumin: an insight into molecular pathways involved in anticancer activity. Mini Rev Med Chem 21(17):2420\u20132457","journal-title":"Mini Rev Med Chem"},{"issue":"8","key":"11734_CR19","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.3390\/antiox11081481","volume":"11","author":"ZJ Yang","year":"2022","unstructured":"Yang ZJ, Huang SY, Zhou DD, Xiong RG, Zhao CN, Fang AP, Zhu HL (2022) Effects and mechanisms of curcumin for the prevention and management of cancers: An updated review. Antioxidants 11(8):1481","journal-title":"Antioxidants"},{"issue":"14","key":"11734_CR20","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.2174\/0118715303320523240910072723","volume":"25","author":"M Singh","year":"2025","unstructured":"Singh M, Verma M, Pandey S, Kumar R, Khan F, Pandey P (2025) Anticancer potential of quercetin, epigallocatechin gallate, kaempferol, apigenin, and curcumin against several human carcinomas. Endocr Metabolic Immune Disorders-Drug Targets 25(14):1148\u20131159","journal-title":"Endocr Metabolic Immune Disorders-Drug Targets"},{"key":"11734_CR21","doi-asserted-by":"publisher","first-page":"153554","DOI":"10.1016\/j.phymed.2021.153554","volume":"90","author":"S Patra","year":"2021","unstructured":"Patra S, Pradhan B, Nayak R, Behera C, Das S, Patra SK, Efferth T, Jena M, Bhutia SK (2021) Dietary polyphenols in chemoprevention and synergistic effect in cancer: Clinical evidences and molecular mechanisms of action. Phytomedicine: Int J phytotherapy phytopharmacology 90:153554. https:\/\/doi.org\/10.1016\/j.phymed.2021.153554","journal-title":"Phytomedicine: Int J phytotherapy phytopharmacology"},{"issue":"20","key":"11734_CR22","doi-asserted-by":"publisher","first-page":"5658","DOI":"10.1080\/10408398.2021.1888693","volume":"62","author":"X Chen","year":"2022","unstructured":"Chen X, Li H, Zhang B, Deng Z (2022) The synergistic and antagonistic antioxidant interactions of dietary phytochemical combinations. Crit Rev Food Sci Nutr 62(20):5658\u20135677","journal-title":"Crit Rev Food Sci Nutr"},{"issue":"17","key":"11734_CR23","doi-asserted-by":"publisher","first-page":"5452","DOI":"10.3390\/molecules27175452","volume":"27","author":"WH Talib","year":"2022","unstructured":"Talib WH, Awajan D, Hamed RA, Azzam AO, Mahmod AI, Al-Yasari IH (2022) Combination anticancer therapies using selected phytochemicals. Molecules 27(17):5452","journal-title":"Molecules"},{"key":"11734_CR24","doi-asserted-by":"publisher","first-page":"153473542210995","DOI":"10.1177\/15347354221099537","volume":"21","author":"AA Saddiq","year":"2022","unstructured":"Saddiq AA, El-Far AH, Mohamed SA, Almaghrabi OA, Mousa SA (2022) Curcumin and thymoquinone combination attenuates breast cancer cell lines\u2019 progression. Integr Cancer Ther 21:15347354221099537","journal-title":"Integr Cancer Ther"},{"issue":"16","key":"11734_CR25","doi-asserted-by":"publisher","first-page":"2137","DOI":"10.3390\/plants11162137","volume":"11","author":"M Younes","year":"2022","unstructured":"Younes M, Mardirossian R, Rizk L, Fazlian T, Khairallah JP, Sleiman C, Rizk S (2022) The synergistic effects of curcumin and chemotherapeutic drugs in inhibiting metastatic, invasive and proliferative pathways. Plants 11(16):2137","journal-title":"Plants"},{"issue":"3","key":"11734_CR26","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1002\/fft2.44","volume":"1","author":"S Kamiloglu","year":"2020","unstructured":"Kamiloglu S, Sari G, Ozdal T, Capanoglu E (2020) Guidelines for cell viability assays. Food Front 1(3):332\u2013349","journal-title":"Food Front"},{"issue":"23","key":"11734_CR27","doi-asserted-by":"publisher","first-page":"7994","DOI":"10.1158\/1078-0432.CCR-04-1087","volume":"10","author":"L Zhao","year":"2004","unstructured":"Zhao L, Wientjes MG, Au JL (2004) Evaluation of combination chemotherapy: integration of nonlinear regression, curve shift, isobologram, and combination index analyses. Clin Cancer Res 10(23):7994\u20138004","journal-title":"Clin Cancer Res"},{"issue":"3","key":"11734_CR28","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1385\/MB:19:3:305","volume":"19","author":"MK Squier","year":"2001","unstructured":"Squier MK, Cohen JJ (2001) Standard quantitative assays for apoptosis. Mol Biotechnol 19(3):305\u2013312","journal-title":"Mol Biotechnol"},{"issue":"10","key":"11734_CR29","doi-asserted-by":"publisher","first-page":"1600","DOI":"10.1002\/cncr.32022","volume":"125","author":"MZ Aumeeruddy","year":"2019","unstructured":"Aumeeruddy MZ, Mahomoodally MF (2019) Combating breast cancer using combination therapy with 3 phytochemicals: Piperine, sulforaphane, and thymoquinone. Cancer 125(10):1600\u20131611","journal-title":"Cancer"},{"issue":"1","key":"11734_CR30","doi-asserted-by":"publisher","first-page":"4","DOI":"10.3390\/ddc4010004","volume":"4","author":"N Chaachouay","year":"2025","unstructured":"Chaachouay N (2025) Synergy, additive effects, and antagonism of drugs with plant bioactive compounds. Drugs Drug Candidates 4(1):4","journal-title":"Drugs Drug Candidates"},{"issue":"9","key":"11734_CR31","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1080\/1061186X.2020.1722136","volume":"28","author":"M Al Fayi","year":"2020","unstructured":"Al Fayi M, Otifi H, Alshyarba M, Dera AA, Rajagopalan P (2020) Thymoquinone and curcumin combination protects cisplatin-induced kidney injury, nephrotoxicity by attenuating NF\u03baB, KIM-1 and ameliorating Nrf2\/HO-1 signalling. J Drug Target 28(9):913\u2013922","journal-title":"J Drug Target"},{"issue":"4","key":"11734_CR32","doi-asserted-by":"publisher","first-page":"773","DOI":"10.5603\/FM.a2019.0027","volume":"78","author":"M Atteya","year":"2019","unstructured":"Atteya M, Ahmed AM, AlRabiah A, Al-Matrafi TA, Arafah MM, Al-Saggaf S, Mohammad RAT (2019) Thymoquinone and curcumin modify inducible nitric oxide synthase, caspase 3, and thioredoxin immunohistochemical expression in acetaminophen hepatotoxicity. Folia Morphol 78(4):773\u2013788","journal-title":"Folia Morphol"},{"issue":"12","key":"11734_CR33","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.3390\/antiox13121573","volume":"13","author":"H Mohd","year":"2024","unstructured":"Mohd H, Michniak-Kohn B (2024) Synergistic Anti-Cancer Effects of Curcumin and Thymoquinone Against Melanoma. Antioxidants 13(12):1573","journal-title":"Antioxidants"},{"issue":"1","key":"11734_CR34","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1186\/s12906-024-04432-2","volume":"24","author":"MS Moulana","year":"2024","unstructured":"Moulana MS, Haiaty S, Bazmani A, Shabkhizan R, Moslehian MS, Sadeghsoltani F, Rahbarghazi R (2024) Tumoricidal properties of thymoquinone on human colorectal adenocarcinoma cells via the modulation of autophagy. BMC Complement Med Ther 24(1):132","journal-title":"BMC Complement Med Ther"},{"key":"11734_CR35","doi-asserted-by":"publisher","first-page":"1119274","DOI":"10.3389\/fnut.2023.1119274","volume":"10","author":"CA Gano","year":"2023","unstructured":"Gano CA, Fatima S, Failes TW, Arndt GM, Sajinovic M, Mahns D, Scott KF (2023) Anti-cancer potential of synergistic phytochemical combinations is influenced by the genetic profile of prostate cancer cell lines. Front Nutr 10:1119274","journal-title":"Front Nutr"},{"issue":"1","key":"11734_CR36","doi-asserted-by":"publisher","first-page":"26064","DOI":"10.1038\/srep26064","volume":"6","author":"K Wang","year":"2016","unstructured":"Wang K, Zhang C, Bao J, Jia X, Liang Y, Wang X, He C (2016) Synergistic chemopreventive effects of curcumin and berberine on human breast cancer cells through induction of apoptosis and autophagic cell death. Sci Rep 6(1):26064","journal-title":"Sci Rep"},{"issue":"4","key":"11734_CR37","first-page":"1246","volume":"52","author":"YC Castellanos-Esparza","year":"2018","unstructured":"Castellanos-Esparza YC, Wu S, Huang L, Buquet C, Shen R, Sanchez-Gonzalez B, Lu H (2018) Synergistic promoting effects of pentoxifylline and simvastatin on the apoptosis of triple-negative MDA-MB-231 breast cancer cells. Int J Oncol 52(4):1246\u20131254","journal-title":"Int J Oncol"},{"issue":"6","key":"11734_CR38","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1007\/s12272-017-0923-0","volume":"40","author":"JE Lee","year":"2017","unstructured":"Lee JE, Kwon YJ, Baek HS, Ye DJ, Cho E, Choi HK, Chun YJ (2017) Synergistic induction of apoptosis by combination treatment with mesupron and auranofin in human breast cancer cells. Arch Pharm Res 40(6):746\u2013759","journal-title":"Arch Pharm Res"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-11734-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-026-11734-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-11734-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T07:26:40Z","timestamp":1774942000000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-026-11734-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,31]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["11734"],"URL":"https:\/\/doi.org\/10.1007\/s11033-026-11734-w","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,31]]},"assertion":[{"value":"6 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"557"}}